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True Uncomplicated Obesity
Is Not Related to Increased Left
Ventricular Mass and Systolic Dysfunction
I found the recent study by Peterson et al. (1) to be quite
interesting. They found that obesity in young and otherwise
healthy women is associated with increased left ventricle (LV)
mass, LV concentric remodeling, and decreased systolic and
diastolic function. I applaud that LV function and diastolic and
systolic functions were obtained by use of second harmonic
imaging and tissue Doppler imaging, a highly sensitive and specific
echocardiographic technique. This procedure allowed the investi-
gators a very accurate evaluation of LV parameters. Nevertheless,
I have some comments on the study design and the results.
The first and main criticism is related to the inclusion criteria
that they applied to define “healthy” obese women. The researchers
put fasting glucose 126 mg/dl or a glucose level 200 mg/dl 2 h
after an oral glucose tolerance test (OGTT) and total cholesterol
level 260 mg/dl and/or triglyceride level 400 mg/dl as cut-off
points to exclude the presence of diabetes mellitus and dyslipide-
mia, respectively. These parameters do not fill the Adult Treat-
ment Panel III guidelines for cardiovascular risk factors (2).
According to the criteria applied in the Peterson et al. (1) study, it
is also not possible to exclude the presence of impaired fasting
glucose and glucose intolerance assessed by fasting glucose between
110 and 125 mg/dl and glucose 140 mg/dl 2 h after an OGTT,
respectively (3). The cut-off point of 400 mg/dl for triglycerides is
not acceptable to define a normal plasma lipid profile. In addition,
the investigators do not report data on high-density lipoprotein
cholesterol (HDL-C) and low- density lipoprotein cholesterol,
widely recognized as cardiac risk factors. Hence, there is no
evidence that these obese women are healthy subjects.
The presence of underevaluated co-morbidities could explain
the finding of increased LV mass and diastolic and systolic
dysfunction in these obese women. In fact, the impact of impaired
fasting glucose, glucose intolerance, low HDL-C, and hypertri-
glyceridemia on LV parameters is well known.
We agree with Peterson et al. (1) that the effects of obesity on
cardiac structure and function in young and otherwise healthy
subjects are still debated. We have performed an investigation on
the influence of excess fat only on cardiac morphology and
function (4). That study showed that obesity per se, although a
disease of long duration, in absence of glucose intolerance, im-
paired fasting glucose, diabetes, hypertension, and dyslipidemia, is
associated only with an impairment of diastolic function and
hyperkinetic systole and not with LV hypertrophy. Obese subjects
without any co-morbidities, called “uncomplicated” obese subjects,
present left atrium and aortic root enlargement as consequences of
impaired diastole and hyperdynamic systole. Hyperkinetic systole,
estimated by both endocardial and midwall parameters, seems to
be due to the increased cardiac work necessary to supply a high
oxygen consumption for the large body surface of obese subjects.
We have not found increased LV mass or true LV hypertrophy in
uncomplicated obese subjects, and insulin resistance seems to be a
determinant of LV mass stronger than body mass index (5).
Nevertheless, this issue is still controversial.
In addition, obese subjects showed an increase of preload,
probably also due to hyperinsulinemia and its sodium retentive
action, leading to the development of LV eccentricity more than
LV concentric remodeling.
The very restricted inclusion criteria that we applied in our
studies in defining “uncomplicated obesity” allowed us to estimate
the influence of obesity per se on LV parameters.
*Gianluca Iacobellis, MD, PhD
*Center for Human Nutrition
The University of Texas Southwestern Medical Center
5323 Harry Hines Boulevard
Dallas, TX 75390-9052
E-mail: gianluca.iaco@tin.it
doi:10.1016/j.jacc.2004.09.012
REFERENCES
1. Peterson LR, Waggoner AD, Schechtman KB, et al. Alterations in left
ventricular structure and function in young healthy obese women:
assessment by echocardiography and tissue Doppler imaging. J Am Coll
Cardiol 2004;43:1399–404.
2. National Cholesterol Education Program (NCEP) expert panel on
detection evaluation, and treatment of high blood cholesterol in adults
(Adult Treatment Panel III) 2002. Third Report of the National
Cholesterol Education Program (NCEP) expert panel on detection,
evaluation, and treatment of high blood cholesterol in adults (Adult
Treatment Panel III) final report. Circulation 2002;106:3143–421.
3. American Diabetes Association diagnosis and classification of diabetes
mellitus. Diabetes Care 2004;27:S5–10.
4. Iacobellis G, Ribaudo MC, Leto G, et al. Influence of excess fat on
cardiac morphology and function: study in uncomplicated obesity. Obes
Res 2002;10:767–73.
5. Iacobellis G, Ribaudo MC, Zappaterreno A, et al. Relationship of
insulin sensitivity and left ventricular mass in uncomplicated obesity.
Obes Res 2003;11:518–24.
2257JACC Vol. 44, No. 11, 2004 Correspondence
December 7, 2004:2247–58
